Evaluation of the short-term host response and biomechanics of an absorbable poly-4-hydroxybutyrate scaffold in a sheep model following vaginal implantation.
biomechanics
degradable scaffold
host response
pelvic organ prolapse
poly-4-hydroxybutyrate
vaginal surgery
Journal
BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
19
11
2021
received:
18
06
2021
accepted:
30
11
2021
pubmed:
6
12
2021
medline:
20
5
2022
entrez:
5
12
2021
Statut:
ppublish
Résumé
To evaluate the host- and biomechanical response to a fully absorbable poly-4-hydroxybutyrate (P4HB) scaffold in comparison with the response to polypropylene (PP) mesh. In vivo animal experiment. KU Leuven Center for Surgical Technologies. Fourteen parous female Mule sheep. P4HB scaffolds were surgically implanted in the posterior vaginal wall of sheep. The comparative PP mesh data were obtained from an identical study protocol performed previously. Gross necropsy, host response and biomechanical evaluation of explants, and the in vivo P4HB scaffold degradation were evaluated at 60- and 180-days post-implantation. Data are reported as mean ± standard deviation (SD) or standard error of the mean (SEM). Gross necropsy revealed no implant-related adverse events using P4HB scaffolds. The tensile stiffness of the P4HB explants increased at 180-days (12.498 ± 2.66 N/mm SEM [p =0.019]) as compared to 60-days (4.585 ± 1.57 N/mm) post-implantation, while P4HB degraded gradually. P4HB scaffolds exhibited excellent tissue integration with dense connective tissue and a moderate initial host response. P4HB scaffolds induced a significantly higher M2/M1 ratio (1.70 ± 0.67 SD, score 0-4), as compared to PP mesh(0.99 ± 0.78 SD, score 0-4) at 180-days. P4HB scaffold facilitated a gradual load transfer to vaginal tissue over time. The fully absorbable P4HB scaffold, in comparison to PP mesh, has a favorable host response with comparable load-bearing capacity. If these results are also observed at longer follow-up in-vivo, a clinical study using P4HB for vaginal POP surgery may be warranted to demonstrate efficacy. Degradable vaginal P4HB implant might be a solution for treatment of POP.
Identifiants
pubmed: 34865300
doi: 10.1111/1471-0528.17040
pmc: PMC9303173
doi:
Substances chimiques
Hydroxybutyrates
0
Polypropylenes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1039-1049Subventions
Organisme : Tepha, Inc., Lexington, MA, USA
Informations de copyright
© 2021 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
Références
Am J Obstet Gynecol. 2016 Sep;215(3):326.e1-9
pubmed: 27001219
Eur Urol Focus. 2020 Jan 15;6(1):190-198
pubmed: 30049658
BJOG. 2022 Jun;129(7):1039-1049
pubmed: 34865300
Int Urogynecol J. 2021 Jun 14;:
pubmed: 34125243
Int Urogynecol J. 2017 Jul;28(7):999-1004
pubmed: 27900401
Int Urogynecol J. 2017 Feb;28(2):171-180
pubmed: 27216918
J Neurochem. 1981 Nov;37(5):1345-8
pubmed: 7299403
Int Urogynecol J. 2010 Sep;21(9):1151-6
pubmed: 20424823
ISRN Surg. 2013 May 28;2013:238067
pubmed: 23781348
Am J Obstet Gynecol. 2010 May;202(5):501.e1-7
pubmed: 20223444
J Urol. 2016 Jul;196(1):261-9
pubmed: 26880411
Nat Med. 2012 Jul 06;18(7):1028-40
pubmed: 22772564
J Mech Behav Biomed Mater. 2018 Dec;88:431-441
pubmed: 30216933
Obstet Gynecol Int. 2012;2012:376251
pubmed: 22291710
Am J Obstet Gynecol. 2001 Jun;184(7):1357-62; discussion 1362-4
pubmed: 11408853
Am J Obstet Gynecol. 2015 Apr;212(4):474.e1-8
pubmed: 25446700
J Sex Med. 2014 Jul;11(7):1848-55
pubmed: 24735345
Int Urogynecol J. 2011 Sep;22(9):1099-108
pubmed: 21562913
Front Bioeng Biotechnol. 2020 Apr 03;8:257
pubmed: 32318554
Expert Rev Obstet Gynecol. 2012 May 1;7(3):249-260
pubmed: 22707980
Am J Obstet Gynecol. 2016 Aug;215(2):206.e1-8
pubmed: 27094962
Neurourol Urodyn. 2017 Mar;36(3):565-573
pubmed: 26840206
Mater Sci Eng C Mater Biol Appl. 2021 Jan;120:111702
pubmed: 33545861
Curr Opin Obstet Gynecol. 2002 Oct;14(5):527-35
pubmed: 12401983
Int Urogynecol J Pelvic Floor Dysfunct. 2006 Sep;17(5):483-8
pubmed: 16362725
BJOG. 2013 Jan;120(2):233-243
pubmed: 23240802
Aesthet Surg J. 2016 Nov;36(suppl 2):S33-S42
pubmed: 27697885
J Mech Behav Biomed Mater. 2017 Oct;74:349-357
pubmed: 28668592
Curr Opin Obstet Gynecol. 2016 Oct;28(5):413-9
pubmed: 27517341
J Am Assoc Lab Anim Sci. 2015 Mar;54(2):198-208
pubmed: 25836967
J Sex Med. 2011 Apr;8(4):1239-45
pubmed: 21235724
J Surg Res. 2013 Oct;184(2):766-73
pubmed: 23582230
J Cell Biochem. 1994 Oct;56(2):155-61
pubmed: 7829573
Acta Biomater. 2012 Mar;8(3):978-87
pubmed: 22166681
Biomaterials. 2017 Jan;112:95-107
pubmed: 27760399
BJOG. 2013 Jan;120(2):224-232
pubmed: 23240801
Hernia. 2012 Apr;16(2):191-7
pubmed: 21972049